Catalan
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

Long Term Physical Activity for Hemodialysis Patients

Només els usuaris registrats poden traduir articles
Inicieu sessió / registreu-vos
L'enllaç es desa al porta-retalls
Estat
Patrocinadors
AURA Sante

Paraules clau

Resum

Patients on chronic hemodialysis present severe physical dysfunctioning associated with a significant reduction of their muscle mass. These two parameters are associated with increased morbidity and mortality along with deconditioning and poor quality of life. There are several studies- usually short term, single center uncontrolled and underpowered- that have shown a significant improvement of the physical, metabolic and dialytic parameters.
There are only few studies that have measured the impact of a long term intradialytic exercise intervention on a supervised manner. This is a multi-center controlled study examining the effects of intradialytic cycling on parameters of physical functioning, body composition, cardiovascular and nutritional status, immunological status and quality of life in a group of clinically stable hemodialysis patients

Descripció

General Context Chronic Kidney Patients (CKD) live a sedentary life. Sedentarity and Sarcopenia worsen during the evolution of CKD with numerous cardiovascular diseases, infectious and other comorbidities. Inactivity may activate and amplify the inflammatory process, hypercoagulability, malnutrition, invoking a vicious circle of further inactivity and deconditioning.

These populations have a very low physical activity profile due to important tiredness, perturbed general condition and bad adaptation in effort. The patients with cardiovascular problems have additional limitations due to breathlessness associated with congestive cardiac failure and intermittent claudication due to peripheral arteriopathy. At the dialysis stages the tiredness is accentuated after the hemodialysis sessions. The days off dialysis are rarely used for practicing a physical activity.

The deconditioning along with the reduction of the physical activity are leading to a de-socializing progressing in the course of the chronic renal failure. In that way the patient feels more and more isolated with a serious eventual impact on the nutrition status and his quality of life.

Regular physical activity in this population of patients is exerting beneficial effects on insulin resistance, inflammation, dialysis efficiency, nutrition and arterial pressure. It may also reduce the intradialytic hypotensive episodes and improve quality of life, without side effects.

The objective of this study is to investigate an improvement of the physical functioning associated with a reprogramming of the autonomous nervous system, a reduction of the pro-inflammatory factors with a reduction of the insulin resistance (reduction of the metabolic syndrome), along with improvements on the immune system functioning for hemodialysis patients participating on a one year intradialytic physical activity program.

Principal objective :

The principal aim of the present study is to show the efficacy of intradialytic physical activity on functional capacity with the sit-to-stand test in 60 seconds (STS60) and the time to perform 5 complete sit-to-stand movements (STS5) along with a 6 minutes' walk test (6MWT).

Secondary objectives :

The secondary objectives are the amelioration of parameters associated with cardiovascular, sympathetic or autonomous nervous system, immune, nutritional, metabolic and inflammatory outcomes among with quality of life.

This is a multicenter, controlled randomized trial

Study description:

Inclusion of patients willing to participate in the study, and consequently their randomization in 2 groups.

The intervention group will benefit from a supervised physical activity during the dialysis session and the other group will carry on with his usual physical activities and have the same tests before and after the trial without undergoing a supervised intradialytic physical activity program

Primary judgment criteria :

The principal criteria will be the effect of an aerobic training program with a warming up phase, followed by 30 minutes of intradialytic cycling on 55% of the VO2max, 3 times a week.

The primary judgement criteria will be the improvement of the Sit-to-stand test in 60 seconds (STS60) and the time to complete 5 sit-to stand movements (STS5) as well as the 6 minutes' walk test (6MWT) from T0 (before the training program) to T12 (12 months after the start of the training period)

Secondary criteria:

- Quality of life parameters evaluated from the questionaries SF36 (The Short Form (36) Health Survey), Borg scale, EVA.

- Physical activity levels: IPAQ (international physical activity questionary).

- Body composition (Fat mass, lean mass, bone mineral density, estimation of the muscular mass) with DEXA (dual-energy x-ray absorptiometry).

- Cardiovascular parameters : Cardiac echography, doppler of the carotid arteries and the lower extremity arteries, 24h cardiac rhythm exploration

- Immune parameters: leucocyte subpopulation functioning

- Nutritional and metabolic parameters: weight, BMI, albumin, pre-albumin, pre- and post-dialytic serum urea and creatinine levels, nPCR (normalised Protein catabolic Rate).

- Inflammatory parameters :(Interleucin) IL1 bêta, IL6, IL8, IL-10, TNF alpha (Tumor necrosis factor alpha), CRP (C reactive protein)

- Dialysis parameters : Kt/v, anemia control : Hemoglobin (Hb), MCV (mean corpuscular volume), ferritin, erythropoetin dosage (EPO).

- Number, etiology and duration of hospitalisations

- Survival in 1 year

Number of participants : 100, ie 50 per group

Layout of the study :

Inclusion of the patient, evaluations at the start of the study protocol, at 6 months and at the end -12 months (M0, M6, M12).

Benefits and risks of this study :

Improvement of functional aerobic capacity, inflammatory status and quality of life. Improvements on the state of pain, autonomy, augmentation of the lean mass with conservation of the muscular mass for the lower extremities and reduction of the total fat mass are expected as well as improvement of the nutritional status, dialysis parameters, anemia control.

The risks are of cardiovascular origin: a possible decompensation of coronary artery disease, peripheral artery disease, taking into consideration that all patients benefit from echo doppler arterial control before the start of the study.

Regular Perdialytic Activity during Dialysis is practiced in AURA Auvergne (Association pour l'Utilisation du Rein Artificiel Santé) since 2 years; there has been no secondary vascular problem associated with the supervised physical activity. Nevertheless, rare tendon problems or articular and muscular pains could be possible on the course of the study

Dates

Darrera verificació: 07/31/2016
Primer enviat: 07/13/2016
Inscripció estimada enviada: 08/03/2016
Publicat per primera vegada: 08/08/2016
Última actualització enviada: 08/03/2016
Publicació de l'última actualització: 08/08/2016
Data d'inici de l'estudi real: 08/31/2016
Data estimada de finalització primària: 08/31/2018
Data estimada de finalització de l’estudi: 04/30/2019

Condició o malaltia

End Stage Renal Disease on Hemodialysis

Intervenció / tractament

Behavioral: Exercisers

Behavioral: Non Exercisers

Fase

-

Grups de braços

BraçIntervenció / tractament
Active Comparator: Exercisers
Intradialytic exercise on stationary bicycles
Behavioral: Exercisers
Patients are exercising for 30-60 min during dialysis on an Rated Perceived Exertion (RPE) Scale between 12 and 14
Placebo Comparator: Non Exercisers
No intradialytic exercise
Behavioral: Non Exercisers
Patients are having their usual physical activity

Criteris d'elegibilitat

Edats elegibles per estudiar 20 Years Per a 20 Years
Sexes elegibles per estudiarAll
Accepta voluntaris saludables
Criteris

Inclusion Criteria:

- Consenting active hemodialysis patients since at least 6 months aged between 20 and 90 y.o.

Exclusion Criteria:

- Unstable angina,

- severe left ventricular dysfunction,

- Ejection fraction < 30%,

- severe peripheral arterial disease,

- lower extremity amputation,

- impossibility of physical effort: pain, uncontrolled bone/muscular disease,

- participation on another study.

Resultat

Mesures de resultats primaris

1. Improvement of the distance covered after walking for 6 minutes (6 minutes walk test) [12 months]

The principal aim of the present study is to show the efficacy of intradialytic physical activity on the improvement of the physical capacity of the patients assessed with the 6 minutes walk test ((6MWT)

Mesures de resultats secundaris

1. Quality of life parameters 1 [12 months]

Quality of life parameters evaluated from the questionnaire SF36 QD

2. Quality of life parameters 2 [12 months]

Quality of life parameters evaluated from the questionnaire Borg scale

3. Quality of life parameters 3 [12 months]

Quality of life parameters evaluated from the EVA scale

4. Physical activity levels [12 months]

Physical activity levels from the questionnary IPAQ (international physical activity questionnairy)

5. Body composition [12 months]

Body composition (Fat mass, lean mass, bone mineral density, estimation of the muscular mass) with DEXA ccanning and bioimpendance

6. Cardiovascular parameters [12 months]

Cardiovascular parameters : Cardiac echography, echodoppler of the carotid arteries and the lower extremity arteries, 24h cardiac rythm exploration

7. Immune parametres [12 months]

Immune parametres: leucocyte subpopulation fonctioning

8. Nutritional and metabolic parameters 1 [12 months]

BMI

9. Nutritional and metabolic parameters 2 [12 months]

serum albumin levels

10. Nutritional and metabolic parameters 3 [12 months]

serum prealbumin levels

11. Nutritional and metabolic parameters 4 [12 months]

pre and post dialytic serum urea levels

12. Nutritional and metabolic parameters 5 [12 months]

pre and post dialytic serum creatinine levels

13. Nutritional and metabolic parameters 6 [12 months]

nPCR (normalised Protein Catabolic Rate)

14. inflammatory parameters 1 [12 months]

IL1 bêta

15. inflammatory parameters 2 [12 months]

IL6

16. inflammatory parameters 3 [12 months]

IL8

17. inflammatory parameters 4 [12 months]

IL-10

18. inflammatory parameters 5 [12 months]

TNF alpha

19. inflammatory parameters 6 [12 months]

CRP

20. Dialysis parameters [12 months]

Kt/V

21. Anemia control 1 [12 months]

Hemoglobin (Hb)

22. Anemia control 2 [12 months]

MCV (mean corpuscular volume)

23. Anemia control 3 [12 months]

Ferritine

24. Anemia control 4 [12 months]

Erythropoetine dosage (EPO).

25. Number of hospitalisations [12 months]

Number of hospitalisations

26. Duration of hospitalisations [12 months]

Duration of hospitalisations

27. Survival [12 months]

Survival in one year

28. Improvement of Sit to Stand test in 60 seconds (STS60) [12 months]

The physical capacity of the patients assessed with the number of cycles performed during a sit-to-stand test in 60 seconds (STS60).

29. Improvement of the time needed to perform 5 Sit to Stand cycles (STS5) [12 months]

Time needed to perform 5 Sit to Stand cycles (STS5)

Uneix-te a la nostra
pàgina de Facebook

La base de dades d’herbes medicinals més completa avalada per la ciència

  • Funciona en 55 idiomes
  • Cures a base d'herbes recolzades per la ciència
  • Reconeixement d’herbes per imatge
  • Mapa GPS interactiu: etiqueta les herbes a la ubicació (properament)
  • Llegiu publicacions científiques relacionades amb la vostra cerca
  • Cerqueu herbes medicinals pels seus efectes
  • Organitzeu els vostres interessos i estigueu al dia de les novetats, els assajos clínics i les patents

Escriviu un símptoma o una malaltia i llegiu sobre herbes que us poden ajudar, escriviu una herba i vegeu malalties i símptomes contra els quals s’utilitza.
* Tota la informació es basa en investigacions científiques publicades

Google Play badgeApp Store badge